Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection

Clinical Microbiology and Infection

Volumn 11, Issue 9, 2005, Pages 744-749

  Einarsdottir H M ^a   Erlendsdottir H ^a   Kristinsson, K G ^a,b   Gottfredsson, M ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Bacteraemia; Invasive infections; Meningitis; Pneumococci; Recurrent infections; Streptococcus pneumoniae

Indexed keywords

OXACILLIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; ICELAND; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; OUTCOMES RESEARCH; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TIME; VACCINATION;

HUMAN IMMUNODEFICIENCY VIRUS; STREPTOCOCCUS PNEUMONIAE;

EID: 23844431569     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01221.x     Document Type: Article

References (37)

1. Mufson MA, Stanek RJ. Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997. Am J Med 1999; 107: 34S-43S.
2. Stanek RJ, Mufson MA. A 20-year epidemiological study of pneumococcal meningitis. Clin Infect Dis 1999; 28: 1265-1272.
3. Laurichesse H, Romaszko JP, Nguyen LT et al. Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dome, France, 1994-1998. Eur J Clin Microbiol Infect Dis 2001; 20: 299-308.
4. Gottfredsson M, Erlendsdottir H, Kristjansson M, Gudmundsson S, Kristinsson KG. A nationwide study of invasive pneumococcal infections in Iceland during a 20 year period [abstract L-900]. In: Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago. Washington, DC: American Society for Microbiology, 2001; 459.
5. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746.
6. Griffiths H, Lea J, Bunch C, Lee M, Chapel H. Predictors of infection in chronic lymphocytic leukaemia (CLL). Clin Exp Immunol 1992; 89: 374-377.
7. Zysk G, Bethe G, Nan R et al. Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease. J Infect Dis 2003; 187: 330-333.
8. Akikusa JD, Kemp AS. Clinical correlates of response to pneumococcal immunization. J Paediatr Child Health 2001; 37: 382-387.
9. Bishof NA, Welch TR, Beischel LS. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J Infect Dis 1990; 162: 248-250.
10. Styrt B. Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med 1990; 88: 33N-42N.
11. Berkowitz F. Bacteremia in hospitalized black South African children. A one-year study emphasizing nosocomial bacteremia and bacteremia in severely malnourished children. Am J Dis Child 1984; 138: 551-556.
12. Nolan J. Alcohol as a factor in the illness of university service patients. Am J Med Sci 1965; 249: 135.
13. Tillotson JR, Lerner AM. Pneumonias caused by gram negative bacilli. Medicine (Baltimore) 1966; 45: 65-76.
14. Nuorti JP, Butler JC, Farley MM et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342: 681-689.
15. Redd SC, Rutherford GW, Sande MA et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990; 162: 1012-1017.
16. Gordon SB, Chaponda M, Walsh AL et al. Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS 2002; 16: 1409-1417.
17. King MD, Whitney CG, Parekh F, Farley MM. Active Bacterial Core Surveillance Team/Emerging Tnfections Program Network. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis 2003; 37: 1029-1036.
18. Jordano Q, Falco V, Almirante B et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38: 1623-1628.
19. Abbott KC, Agodoa LY. Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol 2001; 56: 124-131.
20. Gransden WR, Eykyn SJ, Phillips J. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. BMJ 1985; 290: 505-508.
21. Whitecar JP, Reddin JL, Spink WW. Recurrent pneumococcal meningitis. A review of the literature and studies on a patient who recovered from eleven attacks caused by five serotypes of Diplococcus pneumoniae. N Engl J Med 1966; 274: 1285-1289.
22. Bingen E, Doit C, Bouillie C et al. Multiple recurrences and relapse of Streptococcus pneumoniae meningitis. Lancet 1995; 346: 311.
23. Attwood JT, Williams Y, Feighery C. Impaired IgG responses in a child with homozygous C2 deficiency and recurrent pneumococcal septicaemia. Acta Paediatr 2001; 90: 99-101.
24. Peters TR, Brumbaugh DE, Lawton AR, Crowe JE. Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia. Clin Infect Dis 2000; 31: 1287-1288.
25. Font B, Lliminana C, Fontanals D, Pineda V, Segura F. Eleven-year study of recurrent pneumococcal bacteremia. Eur J Clin Microbiol Infect Dis 2001; 20: 636-638.
26. Rodriguez-Creixems M, Munoz P, Miranda E, Pelaez T, Alonso R, Bouza E. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med 1996; 156: 1429-1434.
27. Turett GS, Blum S, Telzak EE. Recurrent pneumococcal bacteremia: risk factors and outcomes. Arch Intern Med 2001; 161: 2141-2144.
28. Coccia MR, Facklam RR, Saravolatz LD, Manzor O. Recurrent pneumococcal bacteremia: 34 episodes in 15 patients. Clin Infect Dis 1998; 26: 982-985.
29. Orlicek S, Herrod H, Leggiadro R, Luedtke G, English B. Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency. J Pediatr 1997; 130: 284-288.
30. Lee W, Austrian R, Weiser JN. Recurrent pneumococcal bacteremia in normal children. Pediatr Infect Dis J 1994; 13: 231-233.
31. McEllistrem MC, Mendelsohn AB, Pass MA et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis 2002; 185: 1364-1369.
32. Swenson JM, Hill BC, Thornsberry C. Screening pneumococci for penicillin resistance. J Clin Microbiol 1986; 24: 749-752.
33. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158-163.
34. Sanders LA, Rijkers GT, Kuis W et al. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J Allergy Clin Immunol 1993; 91: 110-119.
35. Brown SD, Rybak MJ. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-0202, as part of the PROTEKT US study. J Antimicrob Chemother 2004; 54(suppl 1): 7-15.
36. Hjaltested EK, Bernatoniene J, Erlendsdottir H et al. Resistance in respiratory tract pathogens and antimicrobial use in Icelandic and Lithuanian children. Scand J Infect Dis 2003; 35: 21-26.
37. Fedson DS. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. Clin Infect Dis 1998; 26: 1117-1123.